Feb. 13 at 1:15 PM
$CTXR $CTOR 10-Qs also filed
CTXR 10-Q: https://www.sec.gov/ix?doc=/Archives/edgar/data/1506251/000121390026015878/ea0276447-10q_citius.htm
CTOR 10-Q https://www.sec.gov/ix?doc=/Archives/edgar/data/1851484/000121390026015877/ea0276448-10q_citius.htm
Highlights:
• LYMPHIR
$3.9 million in revenue generated from initial sales in December 2025
• Cash runway through May 2026.
• CTOR reporting
$7.3M as of Dec 31. CTXR reporting
$7.7M as of Dec 31.
• As of December 31, 2025, they paid the Eisai milestone in full and owe a balance of approximately
$6.8 million to Eisai for certain other invoices.
•
$18.25M still owed to Reddy as of Dec 31
• As of Feb 10, CTXR has 22,376,427 shares outstanding
• As of Feb 10, CTOR has 88,275,204 shares outstanding
• The Note Payable to Pagoda was paid in full on Jan 5
• CTXR confirms they received a non-compliance notice on Feb 9 for falling under
$1. They have until Aug 10, 2026 to regain compliance with NASDAQ.
